MGRX 8-K: SEC filing
Filed with the SEC on · accession 0001493152-26-050533
MGRX filed a 8-K (current report) with the SEC on Nov 6, 2026. Mangoceuticals' sole Series B preferred holder approved a new Series D convertible preferred stock designation and related amendment, allowing a potential Regulation A offering of up to 1,000,000 Series D shares at $10.00 per share.
Summary of the filing
Mangoceuticals' sole Series B preferred holder approved a new Series D convertible preferred stock designation and related amendment, allowing a potential Regulation A offering of up to 1,000,000 Series D shares at $10.00 per share. The company also set its combined 2025/2026 annual meeting for December 30, 2026.
Key details
✦ Ask GOAX AI about this filing — what it means for MGRX, what changed since its last filings and what to watch next.
Try it free for 7 days🔔 Want to stay updated on new SEC filings for MGRX?
Click hereFrequently asked questions
What did MGRX file with the SEC on Nov 6, 2026?
MGRX filed a 8-K (SEC filing). Mangoceuticals' sole Series B preferred holder approved a new Series D convertible preferred stock designation and related amendment, allowing a potential Regulation A offering of up to 1,000,000 Series D shares at $10.00 per share. The company also set its combined 2025/2026 annual meeting for December 30, 2026.
How do I read a 8-K?
A report of a major event, filed within four business days: results, deals, leadership changes, bankruptcy and more. The "Item" number tells you the topic (e.g. 2.02 results, 5.02 executive change, 1.01 new agreement, 1.03 bankruptcy). Exhibits (99.1 press release) usually hold the details.
Why are SEC filings important?
Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A 8-K (current report): A report of a major event, filed within four business days: results, deals, leadership changes, bankruptcy and more.
Other MGRX SEC filings
- 8-K · Secondary offeringOct 9, 2026
- 424B5 · Secondary offeringOct 9, 2026
- 8-K · Material agreementOct 1, 2026
- 8-K · Contract lossAug 21, 2026
- 10-Q · SEC filingAug 13, 2026
- 8-K · Delisting noticeAug 4, 2026
- 8-K · Ceo changeJul 30, 2026
- 8-K · SEC filingJul 2, 2026
- 10-Q · SEC filingMay 19, 2026
- NT 10-Q · Late filingMay 15, 2026
Get alerts when MGRX files with the SEC, plus live charts, key levels and news for 13,000+ stocks.
Try SEPT free for 7 days